Compare OSK & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OSK | CAI |
|---|---|---|
| Founded | 1917 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 6.0B |
| IPO Year | 2009 | N/A |
| Metric | OSK | CAI |
|---|---|---|
| Price | $156.84 | $18.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 9 |
| Target Price | ★ $165.64 | $33.67 |
| AVG Volume (30 Days) | 690.9K | ★ 2.0M |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.48% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.14 | N/A |
| Revenue | ★ $7,705,500,000.00 | N/A |
| Revenue This Year | $6.18 | $24.26 |
| Revenue Next Year | $6.56 | $22.60 |
| P/E Ratio | $135.85 | ★ N/A |
| Revenue Growth | ★ 12.83 | N/A |
| 52 Week Low | $76.82 | $17.15 |
| 52 Week High | $180.49 | $42.50 |
| Indicator | OSK | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 42.03 | 36.87 |
| Support Level | $123.32 | $17.15 |
| Resistance Level | $158.53 | $21.47 |
| Average True Range (ATR) | 6.10 | 1.27 |
| MACD | -3.15 | 0.13 |
| Stochastic Oscillator | 25.30 | 31.13 |
Oshkosh is a leading maker of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, including postal, firefighting, refuse/recycling collection, aviation, and construction. It is typically the market share leader or No. 2 player in North America, or even the global leader in the case of its JLG aerial work platform business. The transport segment is a leading provider of light trucks to the military and vehicles to the Postal Service. The vocational segment, featuring brands such as Pierce, AeroTech, and Volterra, offers purpose-built vehicles and equipment to municipalities. The company reports three segments—Access equipment (45% of revenue), Vocational (35%), and Transport (20%) on 2025 revenue of $10.4 billion.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.